These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
155 related articles for article (PubMed ID: 30034937)
1. MiR-125b attenuates human hepatocellular carcinoma malignancy through targeting SIRT6. Song S; Yang Y; Liu M; Liu B; Yang X; Yu M; Qi H; Ren M; Wang Z; Zou J; Li F; Du X; Zhang H; Luo J Am J Cancer Res; 2018; 8(6):993-1007. PubMed ID: 30034937 [TBL] [Abstract][Full Text] [Related]
2. Histone lysine methyltransferase, suppressor of variegation 3-9 homolog 1, promotes hepatocellular carcinoma progression and is negatively regulated by microRNA-125b. Fan DN; Tsang FH; Tam AH; Au SL; Wong CC; Wei L; Lee JM; He X; Ng IO; Wong CM Hepatology; 2013 Feb; 57(2):637-47. PubMed ID: 22991213 [TBL] [Abstract][Full Text] [Related]
3. MicroRNA-125b attenuates epithelial-mesenchymal transitions and targets stem-like liver cancer cells through small mothers against decapentaplegic 2 and 4. Zhou JN; Zeng Q; Wang HY; Zhang B; Li ST; Nan X; Cao N; Fu CJ; Yan XL; Jia YL; Wang JX; Zhao AH; Li ZW; Li YH; Xie XY; Zhang XM; Dong Y; Xu YC; He LJ; Yue W; Pei XT Hepatology; 2015 Sep; 62(3):801-15. PubMed ID: 25953743 [TBL] [Abstract][Full Text] [Related]
4. MicroRNA-125b suppresses the migration and invasion of hepatocellular carcinoma cells by targeting transcriptional coactivator with PDZ-binding motif. Li J; Fang L; Yu W; Wang Y Oncol Lett; 2015 Apr; 9(4):1971-1975. PubMed ID: 25789078 [TBL] [Abstract][Full Text] [Related]
5. MicroRNA-125b induces cancer cell apoptosis through suppression of Bcl-2 expression. Zhao A; Zeng Q; Xie X; Zhou J; Yue W; Li Y; Pei X J Genet Genomics; 2012 Jan; 39(1):29-35. PubMed ID: 22293115 [TBL] [Abstract][Full Text] [Related]
6. miR-125b suppresses the proliferation of hepatocellular carcinoma cells by targeting Sirtuin7. Zhao L; Wang W Int J Clin Exp Med; 2015; 8(10):18469-75. PubMed ID: 26770454 [TBL] [Abstract][Full Text] [Related]
7. Long non-coding RNA HOTTIP is frequently up-regulated in hepatocellular carcinoma and is targeted by tumour suppressive miR-125b. Tsang FH; Au SL; Wei L; Fan DN; Lee JM; Wong CC; Ng IO; Wong CM Liver Int; 2015 May; 35(5):1597-606. PubMed ID: 25424744 [TBL] [Abstract][Full Text] [Related]
8. MicroRNA-548a-5p promotes proliferation and inhibits apoptosis in hepatocellular carcinoma cells by targeting Tg737. Zhao G; Wang T; Huang QK; Pu M; Sun W; Zhang ZC; Ling R; Tao KS World J Gastroenterol; 2016 Jun; 22(23):5364-73. PubMed ID: 27340352 [TBL] [Abstract][Full Text] [Related]
9. Overexpression of microRNA-125b sensitizes human hepatocellular carcinoma cells to 5-fluorouracil through inhibition of glycolysis by targeting hexokinase II. Jiang JX; Gao S; Pan YZ; Yu C; Sun CY Mol Med Rep; 2014 Aug; 10(2):995-1002. PubMed ID: 24865963 [TBL] [Abstract][Full Text] [Related]
10. The clinicopathological significance of decreased miR-125b-5p in hepatocellular carcinoma: evidence based on RT-qPCR, microRNA-microarray, and microRNA-sequencing. Guo YN; Dong H; Ma FC; Huang JJ; Liang KZ; Peng JL; Chen G; Wei KL Int J Clin Exp Pathol; 2019; 12(1):21-39. PubMed ID: 31933718 [TBL] [Abstract][Full Text] [Related]
11. The Protective Role of miR-125b in Hepatocellular Carcinoma: Unraveling Tumor-Suppressive Mechanisms. Dari MAG; Vahedian V; Kempisty B; Morenikeji OB; Farzaneh M; Anbiyaiee A Curr Mol Med; 2024 Jun; ():. PubMed ID: 38859784 [TBL] [Abstract][Full Text] [Related]
12. MicroRNAs miR-125b and miR-100 suppress metastasis of hepatocellular carcinoma by disrupting the formation of vessels that encapsulate tumour clusters. Zhou HC; Fang JH; Shang LR; Zhang ZJ; Sang Y; Xu L; Yuan Y; Chen MS; Zheng L; Zhang Y; Zhuang SM J Pathol; 2016 Dec; 240(4):450-460. PubMed ID: 27577856 [TBL] [Abstract][Full Text] [Related]
13. MicroRNA-125b suppressesed human liver cancer cell proliferation and metastasis by directly targeting oncogene LIN28B2. Liang L; Wong CM; Ying Q; Fan DN; Huang S; Ding J; Yao J; Yan M; Li J; Yao M; Ng IO; He X Hepatology; 2010 Nov; 52(5):1731-40. PubMed ID: 20827722 [TBL] [Abstract][Full Text] [Related]
14. Sirtuin7 oncogenic potential in human hepatocellular carcinoma and its regulation by the tumor suppressors MiR-125a-5p and MiR-125b. Kim JK; Noh JH; Jung KH; Eun JW; Bae HJ; Kim MG; Chang YG; Shen Q; Park WS; Lee JY; Borlak J; Nam SW Hepatology; 2013 Mar; 57(3):1055-67. PubMed ID: 23079745 [TBL] [Abstract][Full Text] [Related]
15. Sirtuin 6 promotes transforming growth factor-β1/H2O2/HOCl-mediated enhancement of hepatocellular carcinoma cell tumorigenicity by suppressing cellular senescence. Feng XX; Luo J; Liu M; Yan W; Zhou ZZ; Xia YJ; Tu W; Li PY; Feng ZH; Tian DA Cancer Sci; 2015 May; 106(5):559-66. PubMed ID: 25683165 [TBL] [Abstract][Full Text] [Related]
16. MicroRNA-504 functions as a tumor suppressor in hepatocellular carcinoma through inhibiting Frizzled-7-mediated-Wnt/β-catenin signaling. Quan H; Li B; Yang J Biomed Pharmacother; 2018 Nov; 107():754-762. PubMed ID: 30142536 [TBL] [Abstract][Full Text] [Related]
17. Suppression of SIRT6 by miR-33a facilitates tumor growth of glioma through apoptosis and oxidative stress resistance. Chang M; Qiao L; Li B; Wang J; Zhang G; Shi W; Liu Z; Gu N; Di Z; Wang X; Tian Y Oncol Rep; 2017 Aug; 38(2):1251-1258. PubMed ID: 28677777 [TBL] [Abstract][Full Text] [Related]
18. MicroRNA-125b promotes apoptosis by regulating the expression of Mcl-1, Bcl-w and IL-6R. Gong J; Zhang JP; Li B; Zeng C; You K; Chen MX; Yuan Y; Zhuang SM Oncogene; 2013 Jun; 32(25):3071-9. PubMed ID: 22824797 [TBL] [Abstract][Full Text] [Related]
19. MicroRNA-203 Increases Cell Radiosensitivity via Directly Targeting Bmi-1 in Hepatocellular Carcinoma. Shao Y; Zhang D; Li X; Yang J; Chen L; Ning Z; Xu Y; Deng G; Tao M; Zhu Y; Jiang J Mol Pharm; 2018 Aug; 15(8):3205-3215. PubMed ID: 29906128 [TBL] [Abstract][Full Text] [Related]
20. Differential expression of plasma microRNA-125b in hepatitis B virus-related liver diseases and diagnostic potential for hepatitis B virus-induced hepatocellular carcinoma. Chen S; Chen H; Gao S; Qiu S; Zhou H; Yu M; Tu J Hepatol Res; 2017 Mar; 47(4):312-320. PubMed ID: 27152955 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]